European Drug Report 2025: Highlights - Rapid drug market shifts create new risks and challenge Europe’s preparedness
European Drug Report 2025: Highlights - Rapid drug market shifts create new risks and challenge Europe’s preparedness
Rapid shifts in Europe's drug market are creating new health and security risks and challenging the region's capacity to respond. This warning comes from the European Union Drugs Agency (EUDA) in its European Drug Report 2025: Trends and Developments, released today (1). Based on data from 29 countries (EU-27, Norway and Türkiye), this annual review highlights latest trends and emerging threats.
Read the key stories:
Europe's stimulant market: cathinones gaining ground
New synthetic opioids: nitazenes pose risk of fatal poisonings
Potent cannabis products and wider availability of semi-synthetic cannabinoids
Cocaine: rising health concerns and high availability
Strengthening EU preparedness on drugs: new EUDA services
(EUDA, Lissabon, 05.06.2025)
https://www.euda.europa.eu/news/2025/rapid-drug-market-shifts-create-new-risks-and-challenge-europe-preparedness_en